2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Communication Disorders: new trials by email Literature Review of Communication Disorders trials Research Report on Communication Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment AM-111 0.4 mg/ml, AM-111 0.8 mg/ml, Placebo - Hearing Loss, Idiopathic Sudden Sensorineural | Phase 3 | Terminated | Auris Medical, Inc. | 56 | 2016-06-01 | 2020-08-07 |
| Non-invasive Repetitive Paraorbital Alternating Current Stimulation Therapy for Aphasia rtACS stimulation (Verum condition), placebo condition - Aphasia | Phase 3 | Terminated | University of Magdeburg | 30 | 2010-12-01 | 2013-12-19 |
Aphasia (1) · Deafness (1) · Ear Diseases (1) · Hearing Disorders (1) · Hearing Loss (1) · Hearing Loss, Sensorineural (1) · Hearing Loss, Unilateral (1) · Language (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Otorhinolaryngologic Diseases (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Speech Disorders (1) · Stroke (1)
Language Disorders (2) · Neurobehavioral Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Behavior (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Communication (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Signs and Symptoms (1) · Speech Disorders (1) · Vascular Diseases (1)
D-JNKI-1 (1)
Auris Medical, Inc. (1) · University of Magdeburg (1)
Canada (1) · Germany (1) · South Korea (1) · United States (1)
Bernhard A Sabel, Prof. Dr. (1) · Thomas Meier (1)